CaƱon, Flavio C.
HRN: 22-99-64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
CEFTRIAXONE 1G (VIAL)
05/04/2023
05/10/2023
IV
2g
Q24
Pleural Effusion, Left Prob PTB Relapse Vs Parapneumonic Process
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes